阴道网片子宫悬吊术与阴道子宫切除联合子宫骶韧带悬吊术对子宫阴道脱垂女性治疗失败的影响:一项随机临床试验
在美国9个盆腔 Floor 疾病网络中心,183名绝经后症状性子宫阴道脱垂女性随机接受阴道网片子宫悬吊术(93例)或阴道子宫切除联合子宫骶韧带悬吊术(90例)。主要复合结局(脱垂再治疗、脱垂超出处女膜或脱垂症状)在48个月内两组无显著差异(校正HR 0.62,95%CI 0.38-1.02;P=0.06;36个月校正失败率26% vs 38%)。子宫悬吊组手术时间更短,但网片暴露更多;作者指出研究结果的不精确性妨碍了确定性结论,需进一步研究。
要点
- 阴道网片子宫悬吊术与阴道子宫切除联合子宫骶韧带悬吊术在36个月校正失败率分别为26% vs 38%,差异未达统计学显著(P=0.06)。
- 子宫悬吊组平均手术时间较子宫切除组缩短45.2分钟(111.5 vs 156.7分钟,P<.001)。
- 子宫悬吊组网片暴露8% vs 0%,子宫切除组输尿管扭结7% vs 0%、肉芽组织11% vs 1%、缝线暴露21% vs 3%。
核心结论
- 在有症状的子宫阴道脱垂接受阴道手术的女性中,与阴道子宫切除联合子宫骶韧带悬吊术相比,阴道网片子宫悬吊术在3年后并未显著降低复合脱垂结局的发生率。
- 然而,研究结果的不精确性妨碍了确定性结论,需要进一步研究评估阴道网片子宫悬吊术是否比阴道子宫切除联合子宫骶韧带悬吊术更有效。
研究设计与样本
- 美国盆腔 Floor 疾病网络9个临床中心开展的随机优效性临床试验,2013年4月至2015年2月入组183名绝经后症状性子宫阴道脱垂女性。
- 93名女性随机接受阴道网片子宫悬吊术,90名随机接受阴道子宫切除联合子宫骶韧带悬吊术;主要分析设计为最后一名随机参与者随访满3年时进行。
- 183名参与者(平均年龄66岁)被随机分组,175名纳入试验分析,169名(97%)完成3年随访。
主要发现
- 主要复合结局(脱垂再治疗、脱垂超出处女膜或脱垂症状)在子宫悬吊术组 vs 子宫切除术组至48个月无显著差异(校正风险比0.62 [95%CI 0.38-1.02];P=0.06;36个月校正失败率26% vs 38%)。
- 子宫悬吊术组平均手术时间低于子宫切除术组(111.5 [标准差39.7] 分钟 vs 156.7 [标准差43.9] 分钟;差值-45.2 [95%CI -57.7至-32.7];P<.001)。
- 不良事件在子宫悬吊术组 vs 子宫切除术组包括网片暴露(8% vs 0%)、术中处理的输尿管扭结(0% vs 7%)、12周后肉芽组织(1% vs 11%)和12周后缝线暴露(3% vs 21%)。
局限性
- 研究结果的不精确性妨碍了确定性结论。
- 需要进一步研究评估阴道网片子宫悬吊术是否比阴道子宫切除联合子宫骶韧带悬吊术更有效。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Vaginal hysterectomy with suture apical suspension is commonly performed for uterovaginal prolapse. Transvaginal mesh hysteropexy is an alternative option. OBJECTIVE: To compare the efficacy and adverse events of vaginal hysterectomy with suture apical suspension and transvaginal mesh hysteropexy. DESIGN, SETTING, PARTICIPANTS: At 9 clinical sites in the US Pelvic Floor Disorders Network, 183 postmenopausal women with symptomatic uterovaginal prolapse were enrolled in a randomized superiority clinical trial between April 2013 and February 2015. The study was designed for primary analysis when the last randomized participant reached 3 years of follow-up in February 2018. INTERVENTIONS: Ninety-three women were randomized to undergo vaginal mesh hysteropexy and 90 were randomized to undergo vaginal hysterectomy with uterosacral ligament suspension. MAIN OUTCOMES AND MEASURES: The primary treatment failure composite outcome (re-treatment of prolapse, prolapse beyond the hymen, or prolapse symptoms) was evaluated with survival models. Secondary outcomes included operative outcomes and adverse events, and were evaluated with longitudinal models or contingency tables as appropriate. RESULTS: A total of 183 participants (mean age, 66 years) were randomized, 175 were included in the trial, and 169 (97%) completed the 3-year follow-up. The primary outcome was not significantly different among women who underwent hysteropexy vs hysterectomy through 48 months (adjusted hazard ratio, 0.62 [95% CI, 0.38-1.02]; P = .06; 36-month adjusted failure incidence, 26% vs 38%). Mean (SD) operative time was lower in the hysteropexy group vs the hysterectomy group (111.5 [39.7] min vs 156.7 [43.9] min; difference, -45.2 [95% CI, -57.7 to -32.7]; P = <.001). Adverse events in the hysteropexy vs hysterectomy groups included mesh exposure (8% vs 0%), ureteral kinking managed intraoperatively (0% vs 7%), granulation tissue after 12 weeks (1% vs 11%), and suture exposure after 12 weeks (3% vs 21%). CONCLUSIONS AND RELEVANCE: Among women with symptomatic uterovaginal prolapse undergoing vaginal surgery, vaginal mesh hysteropexy compared with vaginal hysterectomy with uterosacral ligament suspension did not result in a significantly lower rate of the composite prolapse outcome after 3 years. However, imprecision in study results precludes a definitive conclusion, and further research is needed to assess whether vaginal mesh hysteropexy is more effective than vaginal hysterectomy with uterosacral ligament suspension. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT01802281.
引用
- Nager CW, Visco AG, Richter HE, et al. Effect of Vaginal Mesh Hysteropexy vs Vaginal Hysterectomy With Uterosacral Ligament Suspension on Treatment Failure in Women With Uterovaginal Prolapse: A Randomized Clinical Trial. JAMA. 2019. PMID: 31529008. doi:10.1001/jama.2019.12812
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。